FDA Investigator Scott N Lim

Scott N Lim has conducted inspections on 57 sites in 6 countries as of 20 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
57
Last Inspection Date:
20 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America, India, Canada, United Kingdom of Great Britain and Northern Ireland, Korea (Republic of), Bulgaria
FDA Investigators that have inspected at least one site in common with Scott N Lim:
Alan L Truong, Alan P Kurtzberg, Alanna L Mussawwir Bias, Alex G Kalugin, Alicia Aborg Borm, Amir Alavi, Andrea A Branche, Andrea George, PhD, Angel K Sandhu, Angela E Glenn, Anh M Lac, Anita Narula, PhD, Arindam Dasgupta, PhD, Arsen Karapetyan, Ashar P Parikh, Atul J Agrawal, Barbara J Rincon, Barbara J White, Barbara J Wilcox, PhD, Binh T Nguyen, Bo Chi, PhD, Calvin B Koerner, Carl Lee, Carla J Lundi, Carole L Jones, Carolyn A Renshaw, Carrie A Hughes, Caryn M Mcnab, Cathleen A Carr Sharpe, CDR Ileana Barreto Pettit, CDR Rochelle B Young, RPh, MSA, Cecilia H Kieu, Celena Ngo, Cheryl A Clausen, Chiang Syin, PhD, Christopher D Leach, Christopher M Jenner, Christopher R Czajka, Christopher S Keating, Christopher T Middendorf, Claudia Mperez Kasmarski, Clinton J Lott, Concepcion Cruz, Jr, Connie P Rezendes, Cynthia J Tsui, Daniel J Lahar, Daniel J Roberts, David G Eng, David J Gomes, Deborah A Greco, Diana L Ayala, Diane Cvan Leeuwen, Dipesh K Shah, Donald B Mckechnie, Dr. Mark J Seaton, PhD, Dr. Ralph M Bernstein, PhD, Dustin M James, Dustin P Tran, Dustin R Abaonza, Edith M Gonzalez, Emily Shacter, Eric L Dong, BS, Eric W Anderson, Frances Namuswe, PhD, Gerald Feldman, Gerald M Feldman, PhD, Hao Kiet D Phan, Haoheng Yan, PhD, Henry K Lau, Humberto Z Gomez, Hyung Yul Lee, Isabel Y Espinosa, Jacek Cieslak, PhD, Jacob W Reynolds, Jai P Singh, James C Lee, PharmD, James R Evans, Jannifer L Degroot, Jeanne Fringer, PhD, Jeffrey M Watson, Jeffrey P Raimondi, Jennifer Crumb, Jennifer L Degroot, Jennifer L Johnson, Jennifer Swisher, PhD, Joan T Briones, Joel Welch, PhD, Joey V Quitania, John A Gonzalez, Jose A Lopez, Jose Acruz Gonzalez, Joseph Kutze, PhD, Joseph P Iser, MD, Joseph R Lambert, Joshua P Wireman, Joshua S Hunt, Juan Rjimenez Garcia, June P Page, Junho Pak, Justin A Boyd, Kathryn E King, Keith O Webber, PhD, Keith Webber, PhD, Kelley, Kellia N Hicks, Kenneth S Boehnen, Kent A Conforti, Kevin P Foley, Kham Phommachanh, Khoa Nathanv Tran, Kim Lthomas Cruse, Kouros Kangarli, Kristin M Abaonza, Kurt A Brorson, PhD, Lakisha M Williams, Lam, Lance Mde Souza, MBA, Lance W Bohm, Laurie Graham, Laurie P Norwood, LCDR Jennifer H Rhyu, Liming Zhang, Linan Ha, PhD, Linda F Murphy, Linh Tu, Lisa Shin, Lucila B Nwatu, Mabel M Lee, Maida Henesian (NMI), Marcus A Goshen, Marie K Kinkade, Mariza M Jafary, Marsha W Major, Marshalette O Edwards, Mary Ewilkerson Brinsko, Matthew A Johnson, Matthew B Casale, Mei Chiung Huang (Jo), Michael D Garcia, Michael R Goga, Michael Shanks, MS, Michael T Cyrus, Michelle Rfrazier Jessen, PhD, Mihaly S Ligmond, Mikhail V Ovanesov, PhD, Milos Dokmanovic, PhD, Min Shanmabel Liu, Muralidhara B Gavini, PhD, Nabeela J Chaudhry, Nadeem I Chaudhry, Nancy E Byerly, Natalia Pripuzova, PhD, Nayan J Patel, Nicholas L Hunt, Nicholas Obiri, PhD, Omotunde O Osunsanmi, Patricia F Hughes, PhD, Patrick C Klotzbuecher, Peter Adams, PhD, Peter E Baker, Peter Kessler, PhD, Qing Joanna Zhou, PhD, Raymond T Oji, Reba A Gates, Rebecca Rodriguez, Rebecca T Davis, Reyes Candau Chacon, PhD, Richard Ledwidge (nmi), PhD, Riley C Myers, PhD, Robert D Tollefsen, Roger F Zabinski, Rumany C Penn, PharmD, Ruth Moore, PhD, Saied A Asbagh, Saleem A Akhtar, Sammie P La, Sandra S Saniga, Sangeeta M Khurana, PhD, Santiago Gallardo Johnson, Seneca D Toms, Serge L Beaucage, Sharon K Thoma, PharmD, Sheilyn H Huang, Shelby N Turner, Shelley H Beausoleil, Sherri J Jackson, Sherrie M La, Sidney B Priesmeyer, Sonia R Peterson, Sparky L Bartee, Sri Ramakrishnaiah Yellela, PhD, Stephanie A Slater, MS, Stephanie Barragan, Stuart W Russell, Terrence Gee, Thao T Kwan, Thea C Grome, Theresa Kirkham (NMI), Thomas J Arista, Thomas W Gordon, Thuy T Nguyen, LCDR, Tiara Nbrown Crosen, Timothy C Grome, Timothy T Kapsala, Tomika L Bivens, Tracy Denison, PhD, Truong Xuan Nguyen (Andy), Uttaniti Limchumroon (Tom), Vaishali J Patel, Vashti E Bocker, Victoria L Palmer, Virgilio F Pacio, CSO, Viviana Matta, Walden H Lee, Wayne E Seifert, William A Burkey, William J Leonard, William V Millar, Yen Tso Kuo, Yi Wang, PhD, Yumi J Hiramine, Zachary A Bogorad, Zachary L Stamm, Zhong Li, PhD

Scott N Lim's Documents

Publish Date Document Type Title
August, 2019 FDA 483 G.S. COSMECEUTICAL USA, INC. - Form 483, 2019-08-14
November, 2019 FDA 483 McGuff Compounding Pharmacy Services, Inc. - Form 483, 2019-11-22
July, 2023 FDA 483 Ardelyx, Inc. - Form 483, 2023-07-24
October, 2022 FDA 483 George R. Thompson, M.D. - Form 483, 2022-10-17
April, 2021 FDA 483 EMERY PHARMA - Form 483, 2021-04-09
February, 2020 FDA 483 Northwest Cosmetic Laboratories L.L.C. DBA Elevation Labs, Idaho - Form 483, 2020-02-24
June, 2021 FDA 483 Calvin Scott & Co., Inc. - Form 483, 2021-06-18
April, 2021 EIR EMERY PHARMA - EIR, 2021-04-09
August, 2023 FDA 483 Genentech, Inc. - Form 483, 2023-08-11
July, 2021 FDA 483 NuSil Technology LLC - Form 483, 2021-07-16
September, 2023 FDA 483 Samsung Bioepis Co., Ltd. - Form 483, 2023-09-15
April, 2022 FDA 483 Apollo Health and Beauty Care Inc. - Form 483, 2022-04-15
January, 2020 FDA 483 Columbia Cosmetics Manufacturing, Inc. - Form 483, 2020-01-29
November, 2022 FDA 483 Cidara Therapeutics, Inc. - Form 483, 2022-11-16
March, 2019 FDA 483 Ecolab Inc. - Form 483, 2019-03-29
April, 2019 FDA 483 Spencer Specialty Products, Inc - Form 483, 2019-04-25
January, 2020 FDA 483 Formulation Technology Incorporated - Form 483, 2020-01-10
September, 2019 FDA 483 Response Tuscano and Delucia Group (DBA Entropic Labs) - Form 483R, 2019-11-04
March, 2020 EIR Genentech, Inc. - EIR, 2020-03-17
January, 2024 FDA 483 ASEGUA THERAPEUTICS LLC - Form 483, 2024-01-22
October, 2019 FDA 483 KarePak LLC - Form 483, 2019-10-09
May, 2023 FDA 483 Piangwarin Phaosawasdi, M.D. - Form 483, 2023-05-18
December, 2021 FDA 483 Allure Labs, Inc - Form 483, 2021-12-03
September, 2019 FDA 483 Tuscano and Delucia Group (DBA Entropic Labs) - Form 483, 2019-09-26
August, 2022 FDA 483 Andrew Rezvani, M.D. - Form 483, 2022-08-19
November, 2020 EIR PETNET SOLUTIONS, INC. - EIR, 2020-11-06
May, 2023 FDA 483 Response Piangwarin Phaosawasdi, M.D. - Form 483R, 2023-05-25
April, 2022 FDA 483 Capcium Inc. - Form 483, 2022-04-08
October, 2021 FDA 483 Innovative Intrathecal Solutions, Inc. dba Innovative Compounding Pharmacy - Form 483, 2021-10-26
August, 2019 EIR G.S. COSMECEUTICAL USA, INC. - EIR, 2019-08-14
February, 2022 FDA 483 Ark Pharmacy, PC (dba Regency Medical Pharmacy) - Form 483, 2022-02-24
July, 2020 FDA 483 UCSF Radiopharmaceutical Facility - Form 483, 2020-07-24
December, 2022 FDA 483 Nezabravka Petrova Haytova - Form 483, 2022-12-16
November, 2023 FDA 483 BEIGENE USA INC - Form 483, 2023-11-13
March, 2021 FDA 483 Cardinal Health, Inc. - Form 483, 2021-03-18
May, 2021 EIR PETNET SOLUTIONS, INC. - EIR, 2021-05-07
February, 2024 FDA 483 Hawthorne Effect, Inc. - Form 483, 2024-02-13
June, 2024 FDA 483 St. Helena Hospital IRB - Form 483, 2024-06-26
May, 2024 FDA 483 CELLTRION Inc - Form 483, 2024-05-03
March, 2024 FDA 483 Sally Arai, M.D. - Form 483, 2024-03-06
August, 2024 FDA 483 Robert D. Ferrera, MD - Form 483, 2024-08-27
July, 2024 FDA 483 Comparative Biosciences, Inc - Form 483, 2024-07-30
May, 2024 FDA 483 Joshua D. Woolley, M.D. - Form 483, 2024-05-30

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more